OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $300,000 Invested

2020

Foundation for the National Institutes of Health, Inc.

Sri Pullagura

Pre-competitive Analytical Validation of SV2A PET as a Biomarker of Synaptic Density Project

  • Funding Amount: $300,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Synaptic Plasticity/Neuroprotection
  • Status: Active